Clostridium difficile-associated diarrhoea treated with homologous faeces;Clostridium difficile-assosiert diare behandlet med homolog feces

Tidsskrift for den Norske Laegeforening

Volumn 118, Issue 7, 1998, Pages 1027-1030

  Lund Tønnesen, Stein ^a   Berstad, Arnold ^a   Schreiner, Aksel ^a   Midtvedt, Tore ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; VANCOMYCIN; BOTULINUM TOXIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; COLON BIOPSY; COLONOSCOPY; DIARRHEA; DRUG EFFICACY; FECES; FEMALE; GASTROSTOMY; HUMAN; MALE; RELAPSE; TREATMENT OUTCOME; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PSEUDOMEMBRANOUS COLITIS;

ADULT; AGED; BOTULINUM TOXINS; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0032502297     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Larson HE, Parry JV, Price AB, Davies DR, Dolby J. Undescribed toxin in pseudomembranous colitis. BMJ 1977; 1: 1246-8.
2. Larson HE, Price AB, Honour P. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1978; 1: 1063-6.
3. Bucher A, Nordbø G. Clostridium difficile-infeksjon. Det nosokomiale aspekt. Tidsskr Nor Lægeforen 1995; 115: 1361-4.
4. Pothoulakis C. Pathogenesis of clostridium difficile-associated diarrhoea. Eur J Gastroenterol Hepatol 1996; 8: 1041-7.
5. Jumaa P, Wren B, Tabaqchali S. Epidemiology and typing of Clostridium difficile. Eur J Gastroenterol Hepatol 1996; 8: 1035-40.
6. Williams D, Bergan T, Moosdeen F. Arrival of vankomycin resistance in Staphylococcus aureus. Newsletter of the International society of Chemotherapy. Antibiot Chemother 1997; 2: 1.
7. Centers for Disease Control. Recommendation for preventing the spread of vankomycin resistance. MMWR Morb Mortal Wkly Rep 1995; 44, RR-12: 1.
8. Barlett JG. Management of Clostridium difficile infection and other antibiotic-associated diarrhoeas. Eur J Gastroenterol Hepatol 1996; 8: 1054-61.
9. Fløtterød Ø, Hopen G. Refraktær clostridium difficile-diaré. TidsskrNor Lægeforen 1991; 111: 1364-5.
10. Schwan A, Sjølin S, Trottestam U, Aronsson B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces. Scand J Infect Dis 1984; 16: 211-5.
11. Privitera G, Scarpelinni P, Ortisi G, Nicastro G, Nocolin R, de Lalla F. Prospective study of Clostridium difficile intestinal colonization and disease following single-dose antibiotic propfylaxis in surgery. Antimicrob Agents Chemother 1991; 35: 208-10.
12. Wilson KH, Freter R. Interactions of Clostridium difficile and E. coli with microflora in continuous-flow cultures and gnotobiotic mice. Infect Immun 1986; 54: 354-8.
13. Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile-associated colitis. Lancet 1989; 1: 1156-7.
14. Olson MM, Shanholtzer CJ, Lee JT, Gerding DN. Ten years prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol 1994; 36: 673-9.
15. Barlett JG. An elderly woman with pneumonia and diarrhea: Clostridium difficile-associated colitis. Gastrointestinal Diseases Today 1992; 1: 1-17.
16. Seppala K, Hjelt L, Sipponen P. Colonoscopy in the diagnosis of antibiotic-associated colitis: a prospective study. Scand J Gastroenterol 1981; 16: 465-8.
17. Libby JM, Jortner BS, Wilkins TD. Effects of the two toxins of Clostridium difficile in antibiotic associated cecitis in hamsters. Infect Immun 1982; 36: 822-9.
18. Kim PH, Iaconis JP, Rolfe RD. Immunization of adult hamsters against Clostridium difficile associated ileocecitis and transfer of protection to infant hamsters. Infect Immun 1987; 55: 2984-92.